In conclusion, CBD, through multi-target mechanisms, represents a valid therapeutic tool for the management of epilepsy, Alzheimer’s disease, multiple sclerosis and Parkinson’s disease.’
In conclusion, CBD, through multi-target mechanisms, represents a valid therapeutic tool for the management of epilepsy, Alzheimer’s disease, multiple sclerosis and Parkinson’s disease.’
Date: 11/01/20
URL: https://pubmed.ncbi.nlm.nih.gov/33171772/
Tags: Alzheimer’s disease | Autophagy | cannabidiol | Immune response | RNA-seq
Contact details
LAYV B.V.
Panamalaan 2G
1019 AZ Amsterdam
📍LAYV CBD
hey@layv.co
Chamber of Commerce: 72846461
VAT: NL859258555B01
Products
© 2023 LAYV B.V.